Your browser doesn't support javascript.
loading
Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial.
Yokomizo, Akira; Koga, Hirofumi; Ito, Kazuto; Takezawa, Yutaka; Komiyama, Motokiyo; Nishimura, Kazuo; Yonese, Junji; Hashine, Katsuyoshi; Masumori, Naoya; Arai, Gaku; Saito, Shiro; Shinohara, Mitsuru; Shimizu, Nobuaki; Yamauchi, Atsushi; Satoh, Takefumi; Tochigi, Tatsuo; Kobayashi, Mikio; Fujimoto, Hiroyuki; Kakimoto, Ken-Ichi; Fukui, Iwao; Tsukamoto, Taiji; Nozaki, Miwako; Karasawa, Katsuyuki; Hasumi, Masaru; Ohtani, Mikinobu; Ishiyama, Hiromichi; Kuwahara, Masaaki; Harada, Masaoki; Ohashi, Yasuo; Kotake, Toshihiko; Kakizoe, Tadao; Suzuki, Kazuhiro; Naito, Seiji; Yamanaka, Hidetoshi.
Afiliação
  • Yokomizo A; Department of Urology, Graduate School of Medicine, Kyusyu University, Fukuoka, Japan.
  • Koga H; Department of Urology, Harasanshin Hospital, Fukuoka, Japan.
  • Ito K; Department of Urology, Graduate School of Medicine, Kyusyu University, Fukuoka, Japan.
  • Takezawa Y; Department of Urology, Harasanshin Hospital, Fukuoka, Japan.
  • Komiyama M; Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Nishimura K; Department of Urology, Isesaki Municipal Hospital, Isesaki, Japan.
  • Yonese J; Department of Urology, National Cancer Center Hospital, Tokyo, Japan.
  • Hashine K; Department of Urology, Osaka International Cancer Institute, Osaka, Japan.
  • Masumori N; Department of Urology, Cancer Institute Hospital, Tokyo, Japan.
  • Arai G; Department of Urology, Shikoku Cancer Center, Matsuyama, Japan.
  • Saito S; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Shinohara M; Department of Urology, Dokkyo University Koshigaya Hospital, Koshigaya, Japan.
  • Shimizu N; Department of Urology, Tokyo Medical Center, Tokyo, Japan.
  • Yamauchi A; Department of Urology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
  • Satoh T; Department of Urology, Gunma Cancer Center Hospital, Ohta, Japan.
  • Tochigi T; Department of Urology, Ibaraki Prefectural Central Hospital, Kasama, Japan.
  • Kobayashi M; Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan.
  • Fujimoto H; Department of Urology, Miyagi Cancer Center, Natori, Japan.
  • Kakimoto KI; Department of Urology, Isesaki Municipal Hospital, Isesaki, Japan.
  • Fukui I; Department of Urology, National Cancer Center Hospital, Tokyo, Japan.
  • Tsukamoto T; Department of Urology, Osaka International Cancer Institute, Osaka, Japan.
  • Nozaki M; Department of Urology, Cancer Institute Hospital, Tokyo, Japan.
  • Karasawa K; Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Hasumi M; Department of Radiation Oncology, Dokkyo University Koshigaya Hospital, Koshigaya, Japan.
  • Ohtani M; Department of Radiation Oncology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
  • Ishiyama H; Department of Urology, Gunma Cancer Center Hospital, Ohta, Japan.
  • Kuwahara M; Department of Urology, Ibaraki Prefectural Central Hospital, Kasama, Japan.
  • Harada M; Department of Radiation and Radiation Oncology, Kitasato University, Sagamihara, Japan.
  • Ohashi Y; Sendai Jin-hinyokika, Sendai, Japan.
  • Kotake T; Kanagawa Cancer Center, Yokohama, Japan.
  • Kakizoe T; University of Tokyo, Tokyo, Japan.
  • Suzuki K; Kotake Clinic, Osaka, Japan.
  • Naito S; President, Japan Cancer Society, Tokyo, Japan.
  • Yamanaka H; Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan.
Cancer Med ; 10(10): 3240-3248, 2021 05.
Article em En | MEDLINE | ID: mdl-33932114

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antagonistas de Androgênios Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Aged80 / Humans / Male Idioma: En Revista: Cancer Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antagonistas de Androgênios Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Aged80 / Humans / Male Idioma: En Revista: Cancer Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão
...